08:49 AM EST, 01/06/2025 (MT Newswires) -- SciSparc ( SPRC ) announced Monday the publication of a European patent application that its collaboration partner Clearmind Medicine ( CMND ) submitted with the European Patent Office for a binge behavior psychedelic combination treatment.

The companies are researching combination treatments that integrate psychedelic molecules with the N-acylethanolamines family, SciSparc ( SPRC ) said.

Shares of SciSparc ( SPRC ) soared 188% and Clearmind Medicine ( CMND ) rose 4% in premarket activity Monday.